Jim Brady

Biography

 Jim Brady, MBA, CPA, is MedImmune’s Vice President of Finance. With over twenty-five years of diverse business experience, he has worked in a number of increasingly senior roles across AstraZeneca, becoming recognized for his knowledge, strong team leadership skills and commitment to people development. Jim began his AstraZeneca career in the Internal Audit Group where he became the Operational Audit Manager for North America before being appointed Controller of a subsidiary company of our US business. Jim then moved into Operations as the Site Controller at the Newark Delaware Production Site before moving back to the US commercial business where he was appointed the Director of Finance for US Government, Policy and Managed Markets and then the US Finance Director for Crestor and the Emerging Brands Portfolio. Jim then worked in Global Marketing where he held the role of Executive Director of Finance. More latterly, Jim returned to the Internal Audit Group as the Chief Audit Executive for AstraZeneca. Most recently, he was the Regional Commercial Finance Director for Asia Pacific. Before joining AstraZeneca, Jim worked at Arthur Andersen & Company where he received his accountancy training and qualified as a Certified Public Accountant.  

Research Interest

 Marketing